Fig. 3: Venous and arterial thrombosis-free survival for JAK2V617F positive PV patients from validation cohort stratified by their JAK2V617F VAF (>50% vs ≤50%). | Blood Cancer Journal

Fig. 3: Venous and arterial thrombosis-free survival for JAK2V617F positive PV patients from validation cohort stratified by their JAK2V617F VAF (>50% vs ≤50%).

From: JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

Fig. 3

Kaplan–Meier curves representing venous thrombosis-free survival (A) and arterial thrombosis-free survival (B) including a total of 289 PV patients. The number of patients at risk for each time point is shown below the graph. Tick marks indicate censored data.

Back to article page